Expression of galectins in head and neck squamous cell carcinoma

被引:0
|
作者
Gillenwater, A
Xu, XC
ElNaggar, AK
Clayman, GL
Lotan, R
机构
[1] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT TUMOR BIOL, HOUSTON, TX 77030 USA
[2] UNIV TEXAS, MD ANDERSON CANCER CTR, DEPT PATHOL, HOUSTON, TX 77030 USA
关键词
D O I
10.1002/(SICI)1097-0347(199609/10)18:5<422::AID-HED5>3.0.CO;2-7
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Galectins are carbohydrate-binding proteins thought to be important for cell growth and differentiation, whose expression is altered in some tumors with aggressive phenotype. Our objective was to evaluate the expression of galectins in head and neck squamous cell carcinoma (HNSCC). Methods. Fourteen HNSCC cell lines and four primary tumor specimens were evaluated using immunoblotting, and immunohistochemical analysis was performed on 35 primary HNSCCs. Results. Galectin-1 and galectin-3 were expressed in most HNSCC cell lines and primary tumor specimens. Galectin-1 was detected in the basal layer of normal adjacent mucosa, in connective tissue stroma, and at the periphery of invasive tumor islands. Galectin-3 localized to superficial mucosal layers, and adjacent to keratin pearls in invasive carcinoma. Conclusions. Galectins are manifested in HNSCC tumors and are localized to the cell surface, where they may participate in cellular interactions. The expression pattern of galectins appears to be associated with degree of squamous differentiation, suggesting a potential role for galectins as biologic and differentiation markers in HNSCC. (C) 1996 John Wiley & Sons, Inc.
引用
收藏
页码:422 / 432
页数:11
相关论文
共 50 条
  • [41] Head and neck squamous cell carcinoma in childhood
    de Carvalho, MB
    Sobrinho, JD
    Rapoport, A
    Fava, AS
    Mendes, AF
    Kanda, JL
    Lehn, CN
    Chacra, J
    Menezes, MB
    Walder, F
    Franzi, SA
    MEDICAL AND PEDIATRIC ONCOLOGY, 1998, 31 (02): : 96 - 99
  • [42] Docetaxel and squamous cell carcinoma of the head and neck
    Calais, G
    BULLETIN DU CANCER, 2004, 91 (02) : 167 - 171
  • [43] Immunotherapy for squamous cell carcinoma of the head and neck
    Yokota, Tomoya
    Homma, Akihiro
    Kiyota, Naomi
    Tahara, Makoto
    Hanai, Nobuhiro
    Asakage, Takahiro
    Matsuura, Kazuto
    Ogawa, Takenori
    Saito, Yuki
    Sano, Daisuke
    Kodaira, Takeshi
    Motegi, Atsushi
    Yasuda, Koichi
    Takahashi, Shunji
    Tanaka, Kaoru
    Onoe, Takuma
    Okano, Susumu
    Imamura, Yoshinori
    Ariizumi, Yosuke
    Hayashi, Ryuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (10) : 1089 - 1096
  • [44] Angiogenesis in head and neck squamous cell carcinoma
    Homer, JJ
    Greenman, J
    Stafford, ND
    CLINICAL OTOLARYNGOLOGY, 2000, 25 (03): : 169 - 180
  • [45] Retreatment in head and neck squamous cell carcinoma
    Bourhis, J
    DeCrevoisier, R
    Eschwege, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S129 - S130
  • [46] Oligometastasis in Head and Neck Squamous Cell Carcinoma
    Moon, Dominic H.
    Sher, David J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (04): : 803 - 811
  • [47] Squamous cell carcinoma of the head and neck in the elderly
    Gugic, Jasenka
    Strojan, Primoz
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2013, 18 (01) : 16 - 25
  • [48] Immunotherapy for head and neck squamous cell carcinoma
    Li, Qiao
    Prince, Mark E. P.
    Moyer, Jeffrey S.
    ORAL ONCOLOGY, 2015, 51 (04) : 299 - 304
  • [49] The coagulome of Head and Neck Squamous Cell Carcinoma
    Saidak, Zuzana
    Galmiche, Antoine
    Lottin, Marine
    Montes, Lydia
    Soudet, Simon
    Sevestre, Marie-Antoinette
    Clatot, Florian
    Mirghani, Haitham
    ORAL ONCOLOGY, 2021, 114
  • [50] Exosomes in Head and Neck Squamous Cell Carcinoma
    Xiao, Cheng
    Song, Fang
    Zheng, Yu Long
    Lv, Jiong
    Wang, Qiang Fang
    Xu, Nong
    FRONTIERS IN ONCOLOGY, 2019, 9